Biophytis announces its 2023 financial results and provides an update on its activities
Paris (France) and Cambridge (Massachusetts, United States), April 8, 2024 – 11:00 p.m. – Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a biotechnology company at the clinical stage specializing in the development of treatments for age-related diseases, publishes its operational and financial results for the financial year ending December 31, 2023 and provides an update on the progress of its various programs.